Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AGEDIA: AGEs as Markers in Type 1 Diabetic Children
NCT02793427Unknown
- Sponsor
- CHU de Reims
- Start
- Feb 2011
- Primary completion
- Jun 2019
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by CHU de Reims. Primary endpoint: Serum Advanced Glycation End Products at 5 years. Status: unknown.
Beyond the preview
Go deeper on NCT02793427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02793427.